NP / PA
Driver, Sheila
Driver, Sheila was paid $481K by Medicaid between Jan 2018 and Apr 2019, across 49 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoDRIVER, SHEILA
WEST JEFFERSON, NC 28694
WEST JEFFERSON, NC 28694
33aNPI1215915046assigned 01/03/2006
33bProvider typePediatric Nurse Practitioner
28Total paid$481K
24GClaims16,257
24DCodes billed49
24AFirst – last monthJan 2018 – Apr 2019
Compared with peers
Next to other Pediatric Nurse Practitioner providers in North Carolina
Rank by total paid#1 of 6
Median peer was paid$15K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,436 | $326K | |
| 2019 | 4,821 | $156K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 2,063 | 1,746 | $158K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 2,323 | 1,790 | $118K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 8.4% | 686 | 572 | $40K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7.5% | 1,297 | 1,091 | $36K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.6% | 340 | 297 | $22K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.5% | 282 | 235 | $17K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.4% | 986 | 858 | $17K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.4% | 401 | 346 | $12K |
| 92587 | 2.2% | 440 | 383 | $11K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 90 | 84 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 223 | 180 | $6K |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | 1.1% | 222 | 212 | $5K |
37 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 60 | $5K |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 131 | $5K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,114 | $4K |
| 94664 | <1% | 376 | $3K | |
| 90651 | <1% | 123 | $3K | |
| 88738 | <1% | 361 | $2K | |
| 83655 | <1% | 113 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 57 | $1K |
| 96160 | <1% | 538 | $1K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 27 | $1K |
| 90686 | <1% | 369 | $827.59 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 95 | $749.25 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 406 | $628.90 |
| 90734 | <1% | 33 | $595.05 | |
| 96161 | <1% | 298 | $581.26 | |
| 92552 | <1% | 325 | $508.93 | |
| 92567 | <1% | 317 | $435.44 | |
| 99051 | <1% | 19 | $425.04 | |
| 80061 | Lipid panel | <1% | 26 | $380.19 |
| 96127 | <1% | 123 | $285.52 | |
| 90621 | <1% | 15 | $273.72 | |
| 85018 | <1% | 354 | $216.04 | |
| 87807 | <1% | 14 | $183.69 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 18 | $142.20 |
| 36415 | Collection of venous blood by venipuncture | <1% | 41 | $103.05 |
| 90715 | <1% | 15 | $86.50 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 60 | $81.99 |
| 81002 | <1% | 33 | $63.00 | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 13 | $37.75 |
| 99173 | <1% | 676 | $32.36 | |
| 99177 | <1% | 362 | $18.51 | |
| D1206 | Topical application of fluoride varnish | <1% | 13 | $16.65 |
| 36416 | <1% | 217 | $2.14 | |
| 90633 | 0% | 41 | $0.00 | |
| 90685 | 0% | 37 | $0.00 | |
| 90670 | 0% | 36 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 48 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.